Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US-9161916-B2 · Oct 20, 2015 · US
US10213384B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10213384-B2 |
| Application number | US-201815883134-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 30, 2018 |
| Priority date | Apr 28, 2009 |
| Publication date | Feb 26, 2019 |
| Grant date | Feb 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention teaches a foamable pharmaceutical and cosmetic compositions comprising an aprotic polar solvent; foam compositions and uses thereof.
Opening claim text (preview).
What is claimed is: 1. A non-aqueous composition formulated for skin delivery of an active agent comprising: a minocycline in a therapeutically effective amount of about 1% to about 5% by weight of the composition; a short chain alcohol comprising ethanol present in an amount of at least 55% by weight of the composition; about 12% to about 50% by weight of the composition of a protic polar solvent comprising propylene glycol; a polymeric agent comprising a cellulose ether, wherein the cellulose ether is a hydroxypropyl cellulose present in an amount ranging from about 0.5% to about 1% by weight of the composition; a modulating agent comprising an antioxidizing agent present in an amount ranging from about 0.1% to about 10% by weight of the composition; a metal; and an essential oil, wherein the composition is surfactant free, non-aqueous, and free or essentially free of fatty alcohol. 2. The non-aqueous composition according to claim 1 , wherein the minocycline is dissolved in the composition. 3. The non-aqueous composition according to claim 2 , wherein the minocycline is a minocycline hydrochloride. 4. The non-aqueous composition according to claim 1 , wherein the protic polar solvent is about 12% to about 30% by weight of the composition.
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Drugs for dermatological disorders · CPC title
containing sulfur (A61K8/44 takes precedence) · CPC title
Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters · CPC title
Preparations for care of the skin · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.